Literature DB >> 7560498

Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations.

M Moutafis1, Z Hatahet, M H Castelain, M H Renaudin, A Monnot, M Fischler.   

Abstract

Monitoring of nitric oxide (NO) and nitrogen dioxide (NO2) is a prerequisite for the clinical use of NO. Chemiluminescence, the reference method, cannot be used as a routine in clinical practice in view of its cost and other restraints. This study was performed to evaluate a device using an electrochemical method (Polytrons NO and NO2, Dräger). Forty-nine simultaneous measurements of NO and various oxides of nitrogen (NOx) concentrations by the two apparatus were performed. NO measurements by means of these two methods are very well correlated (r = 0.96; p < 10(-5)). The mean difference according to the method of Bland and Altman was 2.8 +/- 1.7 ppm, with the limits of agreement at -0.6 and +6.2 ppm (confidence interval of 95%). There was also a good correlation between measurements of NO2 obtained via Polytrons and NOx via chemiluminescence (r = 0.84; p < 10(-5)). However, NO2 measurements obtained via Polytrons may be insufficient to exclude potential toxicity of NO2 due to the inability to detect measurements in the ppb-range. This study demonstrates that devices designed for industrial purposes (Polytrons NO and NO2, Dräger) can be used for clinical purposes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560498     DOI: 10.1007/BF01706209

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  19 in total

1.  Safety guidelines for use of nitric oxide.

Authors:  L Foubert; B Fleming; R Latimer; M Jonas; A Oduro; C Borland; T Higenbottam
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

Review 2.  Normobaric pulmonary oxygen toxicity.

Authors:  J Klein
Journal:  Anesth Analg       Date:  1990-02       Impact factor: 5.108

3.  Decreased intrapulmonary killing of Mycoplasma pulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages.

Authors:  J K Davis; M K Davidson; T R Schoeb; J R Lindsey
Journal:  Am Rev Respir Dis       Date:  1992-02

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans.

Authors:  M W Frampton; P E Morrow; C Cox; F R Gibb; D M Speers; M J Utell
Journal:  Am Rev Respir Dis       Date:  1991-03

6.  Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats.

Authors:  D Dreyfuss; G Basset; P Soler; G Saumon
Journal:  Am Rev Respir Dis       Date:  1985-10

7.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

8.  Fate and distribution of inhaled nitrogen dioxide in rhesus monkeys.

Authors:  E Goldstein; N F Peek; N J Parks; H H Hines; E P Steffey; B Tarkington
Journal:  Am Rev Respir Dis       Date:  1977-03

9.  Pulmonary performance of elderly normal subjects and subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide.

Authors:  P E Morrow; M J Utell; M A Bauer; A M Smeglin; M W Frampton; C Cox; D M Speers; F R Gibb
Journal:  Am Rev Respir Dis       Date:  1992-02

10.  Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension.

Authors:  C Girard; J J Lehot; J C Pannetier; S Filley; P Ffrench; S Estanove
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

View more
  6 in total

1.  Pulmonary uptake and modes of administration of inhaled nitric oxide in mechanically-ventilated patients.

Authors: 
Journal:  Crit Care       Date:  1998       Impact factor: 9.097

2.  Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting.

Authors:  D G Markhorst; T Leenhoven; J W Uiterwijk; J Meulenbelt; A J van Vught
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine.

Authors:  S Beloucif; D Payen
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

4.  Bench test assessment of dosage accuracy and measurement inaccuracy in nitric oxide inhalational therapy during high frequency oscillatory ventilation.

Authors:  D G Markhorst; T Leenhoven; H R van Genderingen; J W Uiterwijk; A J van Vught
Journal:  J Clin Monit       Date:  1997-11

5.  Evaluation of electrochemical nitric oxide and nitrogen dioxide analyzers suitable for use during mechanical ventilation.

Authors:  E P Purtz; D Hess; R M Kacmarek
Journal:  J Clin Monit       Date:  1997-01

6.  Direct determination of trace nitrogen dioxide by atmospheric pressure lonization mass spectrometry (APIMS) without conversion to nitric oxide.

Authors:  T Kinoue; S Asai; Y Ishii; K Ishikawa; M Fujii; K Nakano; K Hasumi
Journal:  Environ Health Prev Med       Date:  2000-10       Impact factor: 3.674

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.